Mesalamine Tablet, Delayed Release
Product Images NDC 0591-2245

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0591-2245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

This is a chemical formula for a molecule containing carbon (C), hydrogen (H), nitrogen (N), and oxygen (O). The exact compound name or purpose cannot be determined from this information.*

FDA Label Image

1 (Image 2)

This is prescribing information for Mesalamine Delayed-Release Tablets, USP which come in a bottle containing 120 tablets. The tablets are designed for once-daily use and each contains 5mg of the active ingredient. The medication is dispensed by a pharmacist and must be kept at a controlled room temperature. This product is manufactured by Actavis, a pharmaceutical company based in the United States.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.